$18.600
-0.324 (-1.74%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NVCT Prediction & Forecast by Similar Chart Analysis
Alphio's NVCT stock price prediction model matches the current Nuvectis Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.52 (-0.45%). The 1-week path is $18.73 (+0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Nuvectis Pharma Inc Stock?
Nuvectis Pharma Inc is a good buy right now due to its recent marketing approval for Ciprocopan in China, which is expected to enhance its market position. The current price of $21.12 is below the analyst price target of $34 from Lucid Capital, suggesting a potential upside of 60%. Additionally, the company's year-to-date change of +148.18% and one-year change of +241.20% reflect strong performance, despite recent volatility. The main risk is the negative net income reported, which reached -$7 million in the latest quarter, indicating ongoing financial challenges.
NVCT stock price ended at $18.60 on Friday, after losing -1.74%
Nuvectis Pharma Inc (NVCT) last closed at $18.6, losing -1.74%. These facts feed the 1-day and 1-week NVCT price prediction above.
Forecast Drivers
Nuvectis Pharma Inc (NVCT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches NVCT, ranked by similarity.
Seasonality analysis for NVCT
Historically the probability of a positive October return for NVCT is 65.52%. March offers the highest probability of a positive month at 80.95%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NVCT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $7.82 | $7.98 | $9.18 | -57.08% |
| Nov 2026 | $8.83 | $9.05 | $9.72 | -51.36% |
| Dec 2026 | $8.35 | $9.42 | $10.62 | -49.36% |
In 2026, Nuvectis Pharma Inc (NVCT) is projected to range from $7.82 to $10.62.
Nuvectis Pharma Inc 2026 monthly forecast
In Oct 2026, Nuvectis Pharma Inc is projected to average $7.98, with a low of $7.82 and high of $9.18.
In Nov 2026, Nuvectis Pharma Inc is projected to average $9.05, with a low of $8.83 and high of $9.72.
In Dec 2026, Nuvectis Pharma Inc is projected to average $9.42, with a low of $8.35 and high of $10.62.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.